Login
Toggle navigation
Videos
Categories
Trending
Next-Gen Video Service Unveiled at INTX | Jaison Dolvane - Founder & CEO of Espial Group Inc
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Jaison Dolvane. President/CEO/Co-Founder, Espial Group Inc
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
ROCA Industry Achieves 75% EBITDA Growth in First Half of 2024 | IonuČ› Bindea, CEO, ROCA Industry Holdingrock1 SA.
00:10:00
provides investable assets for diverse angel investors to fund tomorrow's companies|Mark Kraynak,Founding Partner,Acrew Capital
00:10:00
Building a Growth Machine|Brian Balfour,Venture Partner,Long Journey Ventures
00:10:00
Farid Basir, Chief Human Capital Officer at Telekom Malaysia, to speak at Asia's largest HR and Work Tech Conference in February.
00:10:00
Decentralizing Development and Expanding Renewable Energy Investment Opportunities | Mike Crawley, CEO, Northland Power Inc .
00:10:00
Pablo Pereiro on Squirrel Media’s Expansion and Innovation in the Spanish Media Landscape | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Meet Us: Weil's Mentoring & Training Focus | Ronit J. Berkovich - Partner of Weil
00:10:00
Key Success Factors Driving Cool Caps Industries' 48% Annual Growth | Mr. Rajeev Goenka, Chairman, Cool Caps Industries.
00:10:00
Rosario Pingaro, President and CEO of Convergenze SpA, Reflects on the Company's Journey | Rosario Pingaro, CEO, Convergenze SpA Società Benefit.
00:10:00
Lexington Gold Acquires Majority Stake in White Rivers Exploration, Eyeing Millions of Ounces in South Africa | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:00:00
Aleena Garner, PhD Assistant Professor of Neurobiology, HMS
00:00:00
Tomas J. Svoboda, CEO, Elanix Biotechnologies